Jacob Leffert
Assistant Professor
Faculty Researcher
Internal Med, College of Medicine
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Jacob Leffert is an Assistant Professor in the Department of Internal Medicine at the University of Arkansas for Medical Sciences. His research interests include outcomes in patients with multiple myeloma and the impact of vaccination status on clinical outcomes. He has also investigated revaccination status following bone marrow transplant and CAR T-cell therapy. Leffert's scholarship metrics include an h-index of 1, with 4 total publications and 4 total citations. He has collaborated with researchers such as Ankur Varma, Jaskirat Sethi, Toshali Pandey, and Mitchell Jenkins, all from the University of Arkansas for Medical Sciences, on shared publications.
Metrics
- h-index: 1
- Publications: 4
- Citations: 4
Selected Publications
-
Revaccination status after bone marrow transplant and chimeric antigen receptor T-cell therapy. (2025)
-
17. A Retrospective Cohort Study of Influenza Infected Multiple Myeloma Patients Comparing Clinical Outcomes Between Vaccinated and Unvaccinated (2021)
-
HIV-vacuolar myelopathy: an unusual early presentation in HIV (2020)
Collaboration Network
Top Collaborators
- 17. A Retrospective Cohort Study of Influenza Infected Multiple Myeloma Patients Comparing Clinical Outcomes Between Vaccinated and Unvaccinated
- 17. A Retrospective Cohort Study of Influenza Infected Multiple Myeloma Patients Comparing Clinical Outcomes Between Vaccinated and Unvaccinated
- 17. A Retrospective Cohort Study of Influenza Infected Multiple Myeloma Patients Comparing Clinical Outcomes Between Vaccinated and Unvaccinated
- 17. A Retrospective Cohort Study of Influenza Infected Multiple Myeloma Patients Comparing Clinical Outcomes Between Vaccinated and Unvaccinated
- Revaccination status after bone marrow transplant and chimeric antigen receptor T-cell therapy.
- Revaccination status after bone marrow transplant and chimeric antigen receptor T-cell therapy.
- Revaccination status after bone marrow transplant and chimeric antigen receptor T-cell therapy.
- Revaccination status after bone marrow transplant and chimeric antigen receptor T-cell therapy.
Similar Researchers
Based on overlapping research topics